Related Experiment Videos

Intrathecal tolerance of metrizamide in chloralose anesthetized cats

Insights

Metrizamide, a water-soluble radiopaque contrast agent, showed minimal neurological effects in cats compared to hyperosmotic sucrose. Neglumine iothalamate, however, induced significant convulsions and hyperirritability, indicating metrizamide

Area of Science:

  • Neuroscience
  • Radiology
  • Pharmacology

Background:

  • Metrizamide is a water-soluble, radiopaque contrast medium used in medical imaging.
  • Assessing the neurotoxicity of contrast agents is crucial for patient safety.
  • Electromyography (EMG) can detect neurological side effects.

Purpose of the Study:

  • To evaluate the neurological safety of metrizamide administered intrathecally.
  • To compare the neurotoxicity of metrizamide with other intrathecal agents.

Main Methods:

  • Metrizamide was administered intrathecally in anesthetized cats at varying concentrations.
  • Electromyography (EMG) was used to monitor neurological activity.
  • Control groups received cerebrospinal fluid or hyperosmotic sucrose or negrumine iothalamate.

Main Results:

  • Metrizamide administration resulted in mild, occasional muscle fasciculations or spasms, similar to controls.
  • Metrizamide was less deleterious than hyperosmotic sucrose based on EMG.
  • Neglumine iothalamate caused frank convulsions in 7/15 cats and hyperirritability in the rest.

Conclusions:

  • Metrizamide appears to be a relatively safe intrathecal contrast agent with minimal neurotoxic effects.
  • Metrizamide demonstrates a better safety profile compared to negrumine iothalamate and hyperosmotic sucrose.
  • Further studies may be warranted to confirm these findings in different models.

Related Concept Videos